Section Arrow
CLPT.NASDAQ
- ClearPoint Neuro
Quotes are at least 15-min delayed:2025/10/23 20:25 EDT
Regular Hours
Last
 25.27
+0.98 (+4.03%)
Day High 
25.48 
Prev. Close
24.29 
1-M High
30.0999 
Volume 
468.53K 
Bid
25.35
Ask
25.6
Day Low
24.135 
Open
24.36 
1-M Low
11.94 
Market Cap 
690.50M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 25.94 
20-SMA 25 
50-SMA 16.71 
52-W High 30.0999 
52-W Low 9.76 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.80/-0.08
Enterprise Value
693.51M
Balance Sheet
Book Value Per Share
0.69
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
31.39M
Operating Revenue Per Share
0.76
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITGRInteger Holdings Corp73.89-35.22-32.28%46.63PE
QSIQuantum-Si2.2--0.000%-- 
BSXBoston Scientific Corp102.39-1.46-1.41%62.08PE
PMIPicard Medical Inc13.2+0.03+0.23%-- 
PACBPacific Biosciences of California1.95+0.11+5.98%-- 
Quotes are at least 15-min delayed:2025/10/23 20:25 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.